Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

The combination of IL-21 and IFN-alpha boosts STAT3 activation, cytotoxicity and experimental tumor therapy.

Eriksen KW, Søndergaard H, Woetmann A, Krejsgaard T, Skak K, Geisler C, Wasik MA, Odum N.

Mol Immunol. 2009 Feb;46(5):812-20. doi: 10.1016/j.molimm.2008.09.006.

PMID:
18947877
2.

[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].

Herskind C, Fleckenstein K, Lohr J, Li CY, Wenz F, Lohr F.

Strahlenther Onkol. 2004 Apr;180(4):187-93. Review. German.

PMID:
15057428
3.

Histamine and cytokine therapy.

Hellstrand K, Hermodsson S, Naredi P, Mellqvist UH, Brune M.

Acta Oncol. 1998;37(4):347-53. Review.

PMID:
9743456
4.

Antiproliferative activity of IL-27 on melanoma.

Yoshimoto T, Morishima N, Mizoguchi I, Shimizu M, Nagai H, Oniki S, Oka M, Nishigori C, Mizuguchi J.

J Immunol. 2008 May 15;180(10):6527-35.

5.

A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.

Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, Elflein K, Hünig T, Mittrücker HW, Brüstle A, Kamradt T, Lohoff M.

Eur J Immunol. 2009 Jul;39(7):1716-25. doi: 10.1002/eji.200939412.

6.

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.

Hansen ML, Woetmann A, Krejsgaard T, Kopp KL, Søkilde R, Litman T, Straten PT, Geisler C, Wasik MA, Odum N, Eriksen KW.

Mol Immunol. 2011 Sep;48(15-16):2087-93. doi: 10.1016/j.molimm.2011.07.008.

PMID:
21813181
7.

Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.

Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.

Eur J Immunol. 2009 Sep;39(9):2525-36. doi: 10.1002/eji.200838879.

8.
9.

Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.

Liu Z, Yang L, Cui Y, Wang X, Guo C, Huang Z, Kan Q, Liu Z, Liu Y.

Inflamm Bowel Dis. 2009 Aug;15(8):1133-44. doi: 10.1002/ibd.20923.

PMID:
19322899
10.

Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.

Søndergaard H, Coquet JM, Uldrich AP, McLaughlin N, Godfrey DI, Sivakumar PV, Skak K, Smyth MJ.

J Immunol. 2009 Dec 1;183(11):7326-36. doi: 10.4049/jimmunol.0902697.

11.

Anti-retroviral effects of type I IFN subtypes in vivo.

Gerlach N, Gibbert K, Alter C, Nair S, Zelinskyy G, James CM, Dittmer U.

Eur J Immunol. 2009 Jan;39(1):136-46. doi: 10.1002/eji.200838311.

12.

Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.

Sundstedt A, Celander M, Hedlund G.

Int Immunopharmacol. 2008 Mar;8(3):442-52. doi: 10.1016/j.intimp.2007.11.006.

PMID:
18279798
13.

Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.

Hara H, Kobayashi A, Narumi K, Kondoh A, Yoshida K, Nishimoto T, Ohashi M, Higashihara E, Ohnami S, Yoshida T, Aoki K.

Cancer Immunol Immunother. 2009 Jul;58(7):1007-21. doi: 10.1007/s00262-008-0616-0.

PMID:
18998126
14.

The role of interferon-alpha in a successful murine tumor therapy.

Steele TA, Hauser CC.

Exp Biol Med (Maywood). 2005 Jul;230(7):487-93.

PMID:
15985624
16.

Uncoupled anti-HIV and immune-enhancing effects when combining IFN-alpha and IL-7.

Audigé A, Schlaepfer E, Joller H, Speck RF.

J Immunol. 2005 Sep 15;175(6):3724-36.

17.

Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies.

Rodrigues L, Bonorino C.

Expert Rev Vaccines. 2009 Feb;8(2):167-77. doi: 10.1586/14760584.8.2.167. Review.

PMID:
19196197
18.

IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.

Regis G, Icardi L, Conti L, Chiarle R, Piva R, Giovarelli M, Poli V, Novelli F.

Leukemia. 2009 Nov;23(11):2102-8. doi: 10.1038/leu.2009.139.

PMID:
19626047
19.

IFN-beta inhibits human Th17 cell differentiation.

Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S.

J Immunol. 2009 Oct 15;183(8):5418-27. doi: 10.4049/jimmunol.0803227.

20.

Proteome characterization of human NK-92 cells identifies novel IFN-alpha and IL-15 target genes.

Rakkola R, Matikainen S, Nyman TA.

J Proteome Res. 2005 Jan-Feb;4(1):75-82.

PMID:
15707360
Items per page

Supplemental Content

Support Center